Assertio Therapeutics, Inc | Business Contracts

Agreement and Plan of Merger, dated May 19, 2020, by and among Assertio Therapeutics, Inc., Assertio Holdings, Inc., and Alligator Merger Sub, Inc (Filed With SEC on May 22, 2020)

Certificate of Merger dated May 19, 2020 (Filed With SEC on May 22, 2020)

Form of Voting and Support Agreement by and among Alligator Zebra Holdings, Inc. and certain Zyla stockholders (Filed With SEC on March 17, 2020)

Transition Agreement by and among Assertio Therapeutics, Inc. and Arthur Higgins, dated as of March 16, 2020 (Filed With SEC on March 17, 2020)

Agreement and Plan of Merger by and among Assertio Therapeutics, Inc., Alligator Zebra Holdings, Inc., Alligator Merger Sub, Inc., Zebra Merger Sub, Inc. and Zyla Life Sciences,... (Filed With SEC on March 17, 2020)

Description of Securities (Filed With SEC on March 10, 2020)

Asset Purchase Agreement, dated February 6, 2020, by and between Assertio Therapeutics Inc. and Collegium Pharmaceutical, Inc (Filed With SEC on February 20, 2020)

Asset Purchase Agreement, dated February 6, 2020, by and between Assertio Therapeutics Inc. and Collegium Pharmaceutical, Inc (Filed With SEC on February 7, 2020)

Sixth Amendment to Note Purchase Agreement, dated December 11, 2019, by and among Assertio Therapeutics, Inc., certain subsidiaries of Assertio Therapeutics, Inc. party thereto,... (Filed With SEC on December 12, 2019)

Asset Purchase Agreement, dated December 11, 2019, by and among Assertio Therapeutics Inc., Golf Acquiror LLC and, solely for the purposes set forth therein, Celtic Intermediate... (Filed With SEC on December 12, 2019)

First Amendment to Supply Agreement, dated as of July 11, 2019, by and between Assertio Therapeutics, Inc. and Noramco, Inc (Filed With SEC on November 7, 2019)

Form of Amendment No. 1 to Amended and Restated Management Continuity Agreement of Assertio Therapeutics, Inc (Filed With SEC on November 7, 2019)

Third Supplemental Indenture, by and between Assertio Therapeutics, Inc., a Delaware corporation, and the Bank of New York Mellon Trust Company, N.A. as Trustee (Filed With SEC on November 7, 2019)

Form of Exchange Agreement (Filed With SEC on August 9, 2019)

Fifth Amendment to Note Purchase Agreement, dated August 9, 2019 (Filed With SEC on August 9, 2019)

Form of Third Supplemental Indenture, expected to be dated on or around August 13, 2019, by and between Assertio Therapeutics, Inc., a Delaware corporation, and the Bank of New... (Filed With SEC on August 9, 2019)

Amended and Restated Annual Bonus Plan (Filed With SEC on May 9, 2019)

Non-Employee Director Compensation and Grant Policy (Filed With SEC on May 9, 2019)

Assertio Therapeutics, Inc. Amended and Restated 2014 Omnibus Incentive Plan (Filed With SEC on May 8, 2019)

Fourth Amendment to Note Purchase Agreement, dated January 8, 2019 (Filed With SEC on January 9, 2019)

Amended and Restated 2004 Employee Stock Purchase Plan (Filed With SEC on November 9, 2018)

Second Amended and Restated 2004 Equity Incentive Plan (Filed With SEC on November 9, 2018)

Amended and Restated 2014 Omnibus Incentive Plan (Filed With SEC on November 9, 2018)

Form of Equity Award Documents under Amended and Restated 2014 Omnibus Incentive Plan (Filed With SEC on November 9, 2018)

Form of Equity Award Documents for Inducement Grants (Filed With SEC on November 9, 2018)

Settlement Agreement, dated as of August 28, 2018, by and among the Company, Purdue Pharma L.P., Purdue Pharmaceuticals L.P. and The P.F. Laboratories, Inc (Filed With SEC on November 9, 2018)

Amendment No. 2, to Commercialization Agreement, dated as of August 29, 2018, by and among the Company, Collegium Pharmaceutical, Inc. and Collegium NF, LLC (Filed With SEC on November 9, 2018)

Amendment No. 3 to Commercialization Agreement, dated November 8, 2018, by and among Assertio Therapeutics, Inc., Collegium Pharmaceutical, Inc., and Collegium NF, LLC (Filed With SEC on November 8, 2018)

Consent, dated November 8, 2018, by and among Assertio Therapeutics, Inc., certain purchasers and Deerfield Private Design Fund III, L.P (Filed With SEC on November 8, 2018)

Depomed, Inc. Non-Employee Director Compensation and Grant Policy (Filed With SEC on August 8, 2018)

Offer Letter dated June 1, 2018, between the Company and Phillip B. Donenberg (Filed With SEC on August 8, 2018)

Amendment No. 1 to Royalty Purchase and Sale Agreement and Bill of Sale, dated August 2, 2018, by and among Depomed, Inc., Depo DR Sub, LLC, and PDL Investment Holdings, LLC (as... (Filed With SEC on August 8, 2018)

Waiver, Consent and Third Amendment to Note Purchase Agreement and Partial Release of Security Interest, dated August 2, 2018 (Filed With SEC on August 2, 2018)

Office Lease dated February 28, 2018 by and between the Company and Lake Forest Landmark Company LLC (Filed With SEC on May 10, 2018)

Nonemployee Director Compensation and Grant Policy (Filed With SEC on March 1, 2018)

Waiver and Second Amendment to Note Purchase Agreement, dated as of December 4, 2017 (Filed With SEC on December 14, 2017)

Waiver and Release Agreement dated July 12, 2017 by and between the Company and Thadd M. Vargas (Filed With SEC on November 9, 2017)

DEPOMED, INC. Waiver and Release Agreement (Filed With SEC on August 7, 2017)

DEPOMED, INC. AMENDED AND RESTATED ANNUAL BONUS PLAN (as adopted by the Board of Directors on May 17, 2017) (Filed With SEC on May 22, 2017)

DEPOMED, INC. WAIVER AND RELEASE AGREEMENT (Filed With SEC on May 10, 2017)

DEPOMED, INC. MANAGEMENT CONTINUITY AGREEMENT (Filed With SEC on May 10, 2017)

COOPERATION AND SUPPORT AGREEMENT (Filed With SEC on March 29, 2017)

AGREEMENT (Filed With SEC on October 19, 2016)

DEPOMED, INC. AMENDED AND RESTATED ANNUAL BONUS PLAN (as adopted by the Board of Directors on February 12, 2016) (Filed With SEC on May 6, 2016)

DEPOMED, INC. AMENDED AND RESTATED MANAGEMENT CONTINUITY AGREEMENT (Filed With SEC on May 6, 2016)

FIRST AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on April 25, 2016)

SECOND AMENDED AND RESTATED 2004 EQUITY INCENTIVE PLAN OF DEPOMED, INC. (As Amended and Restated on December 20, 2011 and February 12, 2016) (Filed With SEC on February 26, 2016)

DEPOMED, INC. AMENDED AND RESTATED MANAGEMENT CONTINUITY AGREEMENT (Filed With SEC on February 26, 2016)

CONSENT AND FIRST AMENDMENT TO NOTE PURCHASE AGREEMENT (Filed With SEC on February 26, 2016)

DEPOMED, INC. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY, Rights Agent Rights Agreement Dated as of July 12, 2015 (Filed With SEC on July 13, 2015)

NOTE PURCHASE AGREEMENT (Filed With SEC on May 11, 2015)

PLEDGE AND SECURITY AGREEMENT (Filed With SEC on May 11, 2015)

ASSIGNMENT AND CONSENT AGREEMENT (Filed With SEC on May 11, 2015)

TRANSITIONAL SUPPLY AGREEMENT between Janssen Ortho LLC, Janssen Pharmaceuticals, Inc. and Depomed, Inc. DATED AS OF April 2, 2015 (Filed With SEC on May 11, 2015)

SUPPLY AGREEMENT (Filed With SEC on May 11, 2015)

DEPOMED, INC. 2014 OMNIBUS INCENTIVE PLAN (Filed With SEC on February 26, 2015)

DEPOMED, INC. ANNUAL BONUS PLAN (as adopted by the Board of Directors on February 5, 2015) (Filed With SEC on February 26, 2015)

ASSET PURCHASE AGREEMENT between Janssen Pharmaceuticals, Inc. and Depomed, Inc. DATED AS OF JANUARY 15, 2015 (Filed With SEC on February 26, 2015)

DEPOMED, INC. 2.50% CONVERTIBLE SENIOR NOTES DUE 2021 UNDERWRITING AGREEMENT (Filed With SEC on September 9, 2014)

DEPOMED, INC. Issuer AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. Trustee INDENTURE Dated as of September 9, 2014 Senior Debt Securities (Filed With SEC on September 9, 2014)

DEPOMED, INC. AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A, as Trustee First Supplemental Indenture Dated as of September 9, 2014 to Indenture Dated as of September 9, 2014... (Filed With SEC on September 9, 2014)

DEPOMED, INC. ANNUAL BONUS PLAN (as adopted by the Board of Directors on May 21, 2014) (Filed With SEC on May 23, 2014)

DEPOMED, INC. MANAGEMENT CONTINUITY AGREEMENT (Filed With SEC on May 23, 2014)

Depomed, Inc. Bonus Plan (Filed With SEC on May 9, 2014)

DEPOMED, INC. 2004 EMPLOYEE STOCK PURCHASE PLAN As Amended February 19, 2014 (Filed With SEC on March 17, 2014)

ROYALTY PURCHASE AND SALE AGREEMENT dated as of October 18, 2013 between DEPOMED, INC., DEPO DR SUB, LLC, as Seller, and PDL BIOPHARMA, INC., as Purchaser (Filed With SEC on March 17, 2014)

ASSET PURCHASE AGREEMENT by and between NAUTILUS NEUROSCIENCES, INC., as Seller and DEPOMED, INC., as Purchaser Dated as of December 17, 2013 (Filed With SEC on March 17, 2014)

ASSET PURCHASE AGREEMENT by and among ARCHIMEDES PHARMA US INC., ARCHIMEDES PHARMA LTD., ARCHIMEDES DEVELOPMENT LTD. and DEPOMED, INC. July 29, 2013 (Filed With SEC on November 7, 2013)

ASSET PURCHASE AGREEMENT by and between DEPOMED, INC. and XANODYNE PHARMACEUTICALS, INC. Dated as of June 21, 2012 (Filed With SEC on August 3, 2012)

DEPOMED, INC. 2004 EMPLOYEE STOCK PURCHASE PLAN As Amended May 15, 2012 (Filed With SEC on August 3, 2012)

DEPOMED, INC. MANAGEMENT CONTINUITY AGREEMENT (Filed With SEC on August 3, 2012)

Depomed, Inc. Bonus Plan (Filed With SEC on May 18, 2012)

2004 EQUITY INCENTIVE PLAN OF DEPOMED, INC. (As Amended on December 20, 2011) (Filed With SEC on March 8, 2012)

2004 EQUITY INCENTIVE PLAN OF DEPOMED, INC. (As Amended on December 20, 2011) (Filed With SEC on January 17, 2012)

DEPOMED, INC. 2004 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT (Filed With SEC on January 17, 2012)

Patheon Puerto Rico, Inc. and Depomed, Inc. COMMERCIAL MANUFACTURING SERVICES AGREEMENT (Filed With SEC on November 7, 2011)

THIRD LEASE EXTENSION AGREEMENT Building #5 1330 OBrien Drive Menlo Park, California 94025 (Filed With SEC on August 2, 2011)

FOURTH LEASE EXTENSION AGREEMENT Building #6 1360 OBrien Drive Menlo Park, California 94025 (Filed With SEC on August 2, 2011)

SERVICE AGREEMENT (Filed With SEC on August 2, 2011)

DEPOMED, INC. MANAGEMENT CONTINUITY AGREEMENT (Filed With SEC on May 6, 2011)

AMENDMENT TO AMENDED AND RESTATED PROMOTION AGREEMENT (Filed With SEC on May 5, 2009)

DEPOMED, INC. MANAGEMENT CONTINUITY AGREEMENT (Filed With SEC on May 5, 2009)

EXCLUSIVE LICENSE AGREEMENT by and between DEPOMED, INC. and SOLVAY PHARMACEUTICALS, INC. dated November 19, 2008 (Filed With SEC on March 6, 2009)

SETTLEMENTAND LICENSE AGREEMENT (Filed With SEC on August 8, 2008)

2004 EQUITY INCENTIVE PLAN OF DEPOMED, INC. (Filed With SEC on August 8, 2008)

FIRST LEASE EXTENSION AGREEMENT Building #7, Suite H 1430 OBrien Drive Menlo Park, California 94025 (Filed With SEC on August 8, 2008)

SECOND LEASE EXTENSION AGREEMENT Building #5 1330 OBrien Drive Menlo Park, California 94025 (Filed With SEC on August 8, 2008)

THIRD LEASE EXTENSION AGREEMENT Building #6 1360 OBrien Drive Menlo Park, California 94025 (Filed With SEC on August 8, 2008)

LOAN AND SECURITY AGREEMENT (Filed With SEC on August 8, 2008)

PROMOTION AGREEMENT (Filed With SEC on August 8, 2008)

AMENDMENT NO. 1 TO COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on August 8, 2008)

DEPOMED, INC. MANAGEMENT CONTINUITY AGREEMENT (Filed With SEC on March 12, 2008)

TERMINATIONAND ASSIGNMENT AGREEMENT (Filed With SEC on March 12, 2008)

TERMINATION AND ASSIGNMENT AGREEMENT (Filed With SEC on November 8, 2007)

AMENDED AND RESTATED PROMOTION AGREEMENT (Filed With SEC on November 8, 2007)

CONSULTING AGREEMENT (Filed With SEC on October 11, 2007)

CONSULTINGAGREEMENT (Filed With SEC on August 27, 2007)

AMENDMENT NO. 1 TO MANAGEMENT CONTINUITY AGREEMENT (Filed With SEC on August 27, 2007)

2004 EQUITY INCENTIVE PLAN OF DEPOMED, INC. (Filed With SEC on August 8, 2007)

2004 EMPLOYEE STOCK PURCHASE PLAN OF DEPOMED, INC (Filed With SEC on August 8, 2007)

Amendmentto the Supply Agreement (Filed With SEC on August 8, 2007)

COMMON STOCK PURCHASEAGREEMENT (Filed With SEC on April 23, 2007)

AMENDMENT NO. 1 TO STOCK PURCHASE AGREEMENT (Filed With SEC on March 16, 2007)

DEPOMED, INC. 1995 STOCK OPTIONPLAN INCENTIVE STOCKOPTION AGREEMENT (Filed With SEC on March 16, 2007)

DEPOMED, INC. 1995 STOCK OPTION PLAN NONSTATUTORY STOCK OPTIONAGREEMENT (Filed With SEC on March 16, 2007)

DEPOMED, INC. 1995 STOCK OPTIONPLAN NOTICE OF EXERCISE (Filed With SEC on March 16, 2007)

2004 EQUITY INCENTIVE PLAN OF DEPOMED, INC. (Filed With SEC on March 16, 2007)

SUBLICENSE AGREEMENT (Filed With SEC on March 16, 2007)

MOVAPharmaceutical Corporation and Depomed,Inc. COMMERCIALMANUFACTURING AGREEMENT (Filed With SEC on March 16, 2007)

COMMON STOCK PURCHASE AGREEMENT Dated December 11, 2006 by and between DEPOMED, INC. and AZIMUTH OPPORTUNITY LTD. (Filed With SEC on December 12, 2006)

AMENDMENT NO. 1 TO EXCLUSIVE LICENSE AND MARKETING AGREEMENT (Filed With SEC on November 9, 2006)

CO-PROMOTION AGREEMENT (Filed With SEC on November 9, 2006)

LEASE BY AND BETWEEN MENLO BUSINESS PARK, LLC, LESSOR AND DEPOMED, INC., LESSEE (Filed With SEC on November 9, 2006)

LEASE EXTENSION AGREEMENT Building #5 1330 OBrien Drive Menlo Park, California 94025 (Filed With SEC on November 9, 2006)

SECOND LEASE EXTENSION AGREEMENT Building #6 1360 OBrien Drive Menlo Park, California 94025 (Filed With SEC on November 9, 2006)

FORM OFINDEMNIFICATION AGREEMENT (Filed With SEC on November 9, 2006)

PROMOTION AGREEMENT (Filed With SEC on August 7, 2006)

DEPOMED, INC. MANAGEMENTCONTINUITY AGREEMENT (Filed With SEC on May 19, 2006)

DEPOMED, INC. BONUS PLAN (Filed With SEC on April 12, 2006)

MOVA Pharmaceutical Corporation and Depomed, Inc. TECHNOLOGY TRANSFER AND COMMERCIAL MANUFACTURING AGREEMENT (Filed With SEC on March 16, 2006)

AMENDEDAND RESTATED LICENSE AGREEMENT (Extended Release Metformin Formulations Canada) (Filed With SEC on March 16, 2006)

SUPPLY AGREEMENT (Extended ReleaseMetformin Formulations U.S.A.) (Filed With SEC on March 16, 2006)

MANUFACTURINGTRANSFER AGREEMENT (Controlled Release Metformin Formulations USA) (Filed With SEC on March 16, 2006)

EXCLUSIVE LICENSEAND MARKETING AGREEMENT (Filed With SEC on November 9, 2005)

DEPOMED, INC. BONUS PLAN (Filed With SEC on July 15, 2005)

CONVERTIBLENOTE REPURCHASE AGREEMENT (Filed With SEC on June 29, 2005)

DEPOMED, INC. MINIMUM:2,222,223 SHARES MAXIMUM:5,036,000 SHARES COMMON STOCK (no parvalue per share) PLACEMENT AGENCY AGREEMENT Dated January 6, 2005 (Filed With SEC on January 7, 2005)

AGREEMENT (Filed With SEC on December 14, 2004)

AMENDED DEVELOPMENT AND LICENSE AGREEMENT (Extended Release Metformin Formulations) (Filed With SEC on May 4, 2004)

TERMINATION AGREEMENT ELAN CORPORATION, PLC ELAN PHARMAINTERNATIONAL LIMITED ELAN INTERNATIONALSERVICES, LTD. DEPOMED, INC. AND DEPOMED DEVELOPMENT,LTD. INDEX (Filed With SEC on November 14, 2003)

DEPOMED DEVELOPMENT, LTD. EXCLUSIVE LICENSE AGREEMENT TABLE OFCONTENTS (Filed With SEC on November 14, 2003)

6,500,000 Shares DEPOMED,INC. COMMON STOCK (no par value) UNDERWRITING AGREEMENT Dated October 22, 2003 October 22, 2003 (Filed With SEC on October 23, 2003)

LEASE BYAND BETWEEN MENLOBUSINESS PARK, LLC, LESSOR AND DEPOMED,INC., LESSEE (Filed With SEC on August 14, 2003)

LEASE SUMMARY (Filed With SEC on August 14, 2003)

DEPOMED,INC. SECURITIESPURCHASE AGREEMENT April 21,2003 DEPOMED,INC. SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 25, 2003)

FORM OF NOMINEE VOTING COMMITMENT (Filed With SEC on April 25, 2003)

FORM OFDIRECTOR AND OFFICER LOCK-UP AGREEMENT (Filed With SEC on April 25, 2003)

FORM OFWARRANT No. W- 2003 - Shares (Filed With SEC on April 25, 2003)

2002 NONSTATUTORY STOCKOPTION PLAN OF DEPOMED, INC. (Filed With SEC on March 31, 2003)

CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on March 31, 2003)

SETTLEMENT AGREEMENT AND RELEASE (Filed With SEC on December 23, 2002)

STOCK PURCHASE AGREEMENT by and between BIOVAIL LABORATORIES INCORPORATED and DEPOMED, INC. Dated as ofMay 28, 2002 TABLE OF CONTENTS (Filed With SEC on December 23, 2002)

SETTLEMENT AGREEMENT AND RELEASE (Filed With SEC on December 3, 2002)

DEVELOPMENTAND LICENSE AGREEMENT (MetforminGR) (Filed With SEC on July 10, 2002)

STOCK PURCHASE AGREEMENT by and between BIOVAIL LABORATORIES INCORPORATED and DEPOMED, INC. Dated as ofMay 28, 2002 TABLE OF CONTENTS (Filed With SEC on July 10, 2002)

LEASE BY AND BETWEEN MENLO BUSINESS PARK, LLC, LESSOR AND DEPOMED, INC., LESSEE (Filed With SEC on November 14, 2001)

Assertio Therapeutics, Inc (147)